Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02860286
Brief Title: Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

First Submitted : July 27, 2016
First Submitted that Met QC Criteria : August 4, 2016
First Posted : August 9, 2016 (Estimate)

Results First Submitted : November 16, 2020
Results First Submitted that Met QC Criteria : March 16, 2021
Results First Posted : April 9, 2021

Last Update Submitted that Met QC Criteria : March 16, 2021
Last Update Posted : April 9, 2021